Moderator:

Sharmishta Mukherjee

(Kolkata)

Speaker:

Kaushik Biswas

(Kolkata)

Indira Maisnam

(Kolkata)

Glycaemia Management of Hospitalized Patients

09:00AM - 09:20AM

Pinjala Ramakrishna

(Hyderabad)

Peripheral artery disease in DM in India

09:20AM - 09:40AM

Ghanshyam Goyal

(Kolkata)

Antimicrobial therapy of foot ulcer in T2DM in India

09:40AM - 09:50AM

Panel Discussion

09:50AM - 10:10AM

Amarta Shankar Chowdhury

(Durgapur)

Empagliflozin has an edge over Dapagliflozin

10:10AM - 10:30AM

Satyam Chakraborty

(Kolkata)

Dapagliflozin has an edge over Empagliflozin

10:30AM - 10:40AM

Panel Discussion

Chittaranjan Yajnik

(Pune)

Lifecourse evolution of diabetes

01:00PM - 01:20PM

Vinay Dhandania

(Ranchi)

Intermittent fasting in T2DM Boon or Bane

01:20PM - 01:40PM

N. K. Singh

(Dhanbad)

Reversal of Diabetes – Myth or Reality?

01:40PM - 01:50PM

Panel Discussion

01:50PM - 02:10PM

Rajesh Rajput

(Rohtak)

Best Basal Degludec

02:10PM - 02:30PM

Deep Dutta

(New Delhi)

Best Basal Glargine U300

02:30PM - 02:40PM

Panel Discussion

02:40PM - 03:00PM

Manash Barua

(Guwahati)

Best SU is Glimepiride

03:00PM - 03:20PM

Sambit Das

(Bhubaneswar)

Best SU is Gliclazide

03:20PM - 03:30PM

Panel Discussion

03:30PM - 03:50PM

Saptarshi Bhattacharya

(New Delhi)

Approach to T2DM patients requiring 100 units insulin per day

03:50PM - 04:10PM

Manoj Chawla

(Mumbai)

Clinical relevance of glycaemic variability in the Indian context

04:10PM - 04:20PM

Panel Discussion

04:20PM - 04:40PM

Rakesh Sahay

(Hyderabad)

Pitfalls in interpreting HbA1C

04:40PM - 05:00PM

Sunil Kota

(Berhampur)

Pitfalls in interpreting biochemical tests in diabetes (K,lipid,fruct)

05:00PM - 05:10PM

Panel Discussion

05:10PM - 05:30PM

Soumik Goswami

(Kolkata)

Clinical Inertia and Reverse Clinical Inertia in T2DM management

05:30PM - 05:50PM

Nilakshi Deka

(Guwahati)

Less is more: Exploring the impact of DPP-4i as an add-on to Insulin in T2DM

05:50PM - 06:10PM

Panel Discussion

06:10PM - 06:30PM

Ashu Rastogi

(Chandigarh)

Intensification in T2DM

06:30PM - 06:50PM

Ajay Kumar

(Patna)

Diabetic Comorbidities focus on HF and CKD

06:50PM - 07:10PM

Panel Discussion

07:10PM - 07:30PM

Abhay Sahoo

(Bhubaneswar)

Position of 2nd generation Sulfonylureas in the Current era

07:30PM - 07:35PM

Subrato Pal

(Kolkata)

Diagnosis of MAFLD- Role of clinical scoring and imaging

07:35PM - 08:10PM

PANEL DISCUSSION: "OBESITY AS A COMMON DENOMINATOR FOR MAFLD, NASH & CVD IN THE 21ST CENTURY"

Panelists:

Kuntal Bhattacharyya

(Kolkata)

Ritesh Ku Agrawala

(Bhubaneswar)

08:10PM - 08:40PM

Rajiv Kovil

(Mumbai)

Sanjay Bhadada

(Chandigarh)

Clinical Case Seminar : Once daily insulins in clinical practice - Looking through the patient lens

08:40PM - 09:10PM

A. K. Singh

(Kolkata)

K. K. Gangopadhyay

(Kolkata)

Exploring the Potential of Oral Semaglutide: A Conversation on Current Applications and Future Direction

09:00AM - 09:20AM

Liza Das

(Chandigarh)

Approach to a 58-yr-old ambulatory person with T2DM and a serum sodium value of 126 mmol/L

09:20AM - 09:40AM

Ganapati Bantwal

(Bengaluru)

Endocrine causes of hypokalemia - cased-based presentation to highlight differential diagnosis

09:40AM - 09:50AM

Panel Discussion

09:50AM - 10:10AM

Satinath Mukhopadhyay

(Kolkata)

Physiology of glucose counterregulatory responses to hypoglycemia - what goes wrong during hypoglycemia unawareness

10:10AM - 10:30AM

Anil Bhansali

(Chandigarh)

Spontaneous hypoglycemia (non-diabetic person) - case based presentation to highlight differential diagnosis

10:30AM - 10:40AM

Panel Discussion

10:40AM - 11:00AM

S. V. Madhu

(New Delhi)

Weight loss achieved with GLP-1RAs - Brief mention of available clinical data with primary focus on mechanism(s) of action

11:00AM - 11:20AM

Lakshmi Nagendra

(Mysuru)

Weight loss achieved with GLP-1 + GIPRA - Brief mention of available clinical data with primary focus on mechanism(s) of action

11:20AM - 11:40AM

A. K. Singh

(Kolkata)

Weight loss achieved with GLP-1 + GIP + Glucagon RA - Brief mention of available clinical data with primary focus on mechanism(s) of action

01:00PM - 01:20PM

Mayur Agrawal

(Bhopal)

37-year-old male with gynecomastia-algorithmic approach to arrive at the diagnosis

01:20PM - 01:40PM

Sujoy Majumdar

(Kolkata)

74-year-old male with non-specific symptoms [9 AMT: 260 ng/dL (9 nmol/L) and LH7 IU/L] - to treat or not-to-treat with T

01:40PM - 01:50PM

Panel Discussion

01:50PM - 02:10PM

M. S. Kushe

(Goa)

Anti-resorptive agents to treat osteoporosis (when, which one, and for how long)

02:10PM - 02:30PM

Thomas Paul

(Vellore)

Anabolic agents to treat osteoporosis (when which one, and for how long)

02:30PM - 02:40PM

Panel Discussion

02:40PM - 03:00PM

Debmalya Sanyal

(Kolkata)

Approach to a 32-year-old diabetic person with hypertension and hypokalemia - case(s) based presentation

03:00PM - 03:20PM

Alpesh Goyal

(Bhopal)

Approach to a 22-year-old male with a confirmed 4 cm retroperitoneal paraganglioma - case(s) based presentation

03:20PM - 03:30PM

Panel Discussion

03:30PM - 03:50PM

Vageesh Ayyar S.

(Bengaluru)

25-year-old female (BMI 28kg/m2) with irregular periods (no galactorrhea) and serum prolactin value of 46ng/mL - when to treat?

03:50PM - 04:10PM

Rajesh Khadgawat

(New Delhi)

Suppression of HPA axis due to exogenous steroid intake-diagnosis, treatment, how & when to discontinue replacement therapy

04:10PM - 04:20PM

Panel Discussion

04:20PM - 04:40PM

KVS Hari Kumar

(Hyderabad)

Prevention and management of "hungry bone syndrome

04:40PM - 05:00PM

Narendra Kotwal

(Pune)

Secondary hyper parathyroidism - definition, common causes, and management of SHPT due to CKD ("role of calcimimetics")

05:00PM - 05:10PM

Panel Discussion